APA引文

Taylor, M., Antonia, S., Bendell, J., Calvo, E., Jäger, D., de Braud, F., . . . Eder, J. P. (2015). Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032. J Immunother Cancer.

Citação norma Chicago

Taylor, Matthew, et al. "Phase I/II Study of Nivolumab With or Without Ipilimumab for Treatment of Recurrent Small Cell Lung Cancer (SCLC): CA209-032." J Immunother Cancer 2015.

MLA引文

Taylor, Matthew, et al. "Phase I/II Study of Nivolumab With or Without Ipilimumab for Treatment of Recurrent Small Cell Lung Cancer (SCLC): CA209-032." J Immunother Cancer 2015.